Eledon Pharmaceuticals, Inc. (ELDN) Financials

ELDN Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 146.7 million 46.2 million
Dec. 31, 2025 169.0 million 87.9 million
Sept. 30, 2025 129.9 million 94.5 million
June 30, 2025 144.9 million 38.9 million

ELDN Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -22.6 million 2.2 million
Dec. 31, 2025 -14.1 million 2.5 million
Sept. 30, 2025 -14.5 million 2.4 million
June 30, 2025 -17.7 million 2.7 million

ELDN Net Income

No data available :(

ELDN Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 111.1 million - 186000
Dec. 31, 2025 133.3 million - 641000
Sept. 30, 2025 93.4 million - 722000
June 30, 2025 107.6 million - 803000

ELDN Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 112.4 million
Dec. 31, 2025 75.4 million
Sept. 30, 2025 77.2 million
June 30, 2025 77.2 million

ELDN Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 - 17.2 million 4.0 million -
Dec. 31, 2025 - 17.5 million 4.0 million -
Sept. 30, 2025 - 15.0 million 4.1 million -
June 30, 2025 - 20.3 million 4.5 million -

ELDN Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 - -
Dec. 31, 2025 - -
Sept. 30, 2025 - -
June 30, 2025 - -

ELDN

Price: $3.48

52 week price:
1.35
4.60

Earnings Per Share: -0.77 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 24400

Market Capitalization: 215.8 million

Links: